Avalon Trust’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2K | Hold |
2,650
| – | – | ﹤0.01% | 298 |
|
|
2025
Q1 | $31.5K | Hold |
2,650
| – | – | ﹤0.01% | 305 |
|
|
2024
Q4 | $49.9K | Sell |
2,650
-1,500
| -36% | -$28.3K | ﹤0.01% | 228 |
|
|
2024
Q3 | $93.3K | Sell |
4,150
-2,906
| -41% | -$65.3K | 0.01% | 172 |
|
|
2024
Q2 | $147K | Hold |
7,056
| – | – | 0.01% | 143 |
|
|
2024
Q1 | $104K | Hold |
7,056
| – | – | 0.01% | 172 |
|
|
2023
Q4 | $72.8K | Hold |
7,056
| – | – | 0.01% | 181 |
|
|
2023
Q3 | $55.5K | Hold |
7,056
| – | – | 0.01% | 183 |
|
|
2023
Q2 | $70.5K | Hold |
7,056
| – | – | 0.01% | 183 |
|
|
2023
Q1 | $62.7K | Buy |
+7,056
| New | +$62.7K | 0.01% | 186 |
|